Investor Relations

Home > Investor Relations > IR Library > Balance Sheets (consolidated)

Balance Sheets (consolidated)

(million yen) 
  FY2015
(2015/4/1-2016/3/31)
FY2016
(2016/4/1-2017/3/31)
(Assets)
Current assets
   
Cash and deposits 20,526 9,444
Notes and accounts receivable 19,818 19,627
Electronically recorded monetary claims 5,984 6,597
Marketable securities 5,000 6,000
Finished products 21,039 22,510
Interim products 4,306 5,863
Raw materials and stored goods 11,745 11,157
Deferred tax assets 1,078 1,002
Currency swaps 2,343 1,841
Other current assets 3,564 2,511
Allowance for doubtful accounts 275 4
Total current assets 95,132 86,552
Fixed assets    
Buildings and structures (net) 24,170 29,830
Machineries, equipments and carriers (net) 14,618 15,148
Land 10,025 10,035
Constructions in progress 8,146 18,279
Other tangible fixed assets (net) 1,809 1,610
Total tangible fixed assets 58,770 74,904
Intangible fixed assets 1,127 1,894
Investments    
Investment securities 564 531
Stock of subsidiaries and associates - 54
Deferred tax assets - 13
Net defined benefit asset 44 40
Others 1,220 1,262
Allowance for doubtful accounts 7 6
Total investments and other assets 1,821 1,895
Total fixed assets 61,719 78,695
Total assets 156,851 165,247

(million yen) 
  FY2015 FY2016
(Liabilities)
Current liabilities
   
Trade notes and accounts payable 6,954 5,309
Electronically recorded obligations-operating 7,182 7,455
Short-term debt 1,740 1,740
Current portion of long-term debt 2,033 2,681
Accrued expenses 5,379 5,112
Accrued income taxes 258 885
Accrued bonuses for directors and Auditors 87 72
Notes payable-equipment 3,034 6,686
Accounts payable-equipment 3,473 3,679
Other current liabilities 1,118 978
Total current liabilities 31,262 34,601
Long-term liabilities    
Convertible bond 15,067 15,056
Long-term debt 38,435 39,253
Deferred tax liabilities 96 40
Net defined benefit liability 221 188
Accrued retirement benefits for directors and Auditors 151 154
Other long-term liabilities 1,012 1,007
Total long-term liabilities 54,984 55,701
Total liabilities 86,246 90,302
(Net Assets)
Shareholders' equity
   
Capital stock 4,717 4,717
Capital surplus 7,870 7,870
Retained earnings 63,821 67,879
Treasury stock 5,639 5,639
Total shareholders' equity 70,769 74,827
Other accumulated comprehensive income    
Difference on revaluation of marketable securities 95 85
Remeasurements of defined benefit plans 260 31
Total other accumulated comprehensive income 164 117
Total net assets 70,605 74,945
Total liabilities and net assets 156,851 165,247

Home > Investor Relations > IR Library > Balance Sheets (consolidated)
© Copyright TOWA PHARMACEUTICAL CO.,LTD. All Rights Reserved.